Yuval Cohen
Vorstandsvorsitzender bei CORBUS PHARMACEUTICALS HOLDINGS, INC.
Vermögen: 350 176 $ am 30.04.2024
Profil
Yuval Cohen is the founder of Celsus Therapeutics Plc, which was founded in 2005.
He held the title of Director & Senior Vice President at Celsus Therapeutics Plc in 2013.
Currently, Dr. Cohen is the Chief Executive Officer & Director at Corbus Pharmaceuticals, Inc. since 2013 and the Chief Executive Officer & Director at Corbus Pharmaceuticals Holdings, Inc. since 2014.
Dr. Cohen's education includes an undergraduate degree from the University of Cape Town and a doctorate degree from Université de Paris 5 René Descartes.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.03.2024 | 10 453 ( 0,10% ) | 350 176 $ | 30.04.2024 |
Aktive Positionen von Yuval Cohen
| Unternehmen | Position | Beginn |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Vorstandsvorsitzender | 11.04.2014 |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Vorstandsvorsitzender | 01.07.2013 |
Ehemalige bekannte Positionen von Yuval Cohen
| Unternehmen | Position | Ende |
|---|---|---|
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Gründer | 01.12.2013 |
Ausbildung von Yuval Cohen
| University of Cape Town | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
